A public health expert explains how GLP-1 drugs have changed the way healthcare providers understand and treat obesity.

Individuals with obesity may experience a lower incidence of acute complications following TBI, supporting the "obesity paradox." ...

A Lancet study warns that obesity sharply increases the risk of severe infections and death, linking excess weight to nearly ...

India’s obesity rates are predicted to rise substantially and by 2050, it is estimated that 17.4% of women and 12.1% of men will be living with it, s ...

The global obesity drugs market is projected to grow at a robust compound annual growth rate (CAGR) of approximately 25% ...

The European Commission has granted final approval of a higher 7.2 mg maintenance dose of Wegovy® (semaglutide) for adults ...

Excess body fat impairs immune responses, promotes chronic inflammation, and restricts lung expansion. As a result, ...

Researchers have quantified the role of obesity in common long-term conditions, showing for the first time the effect of ...

By Dr. Priyom Bose, Ph.D. A sweeping genetic analysis reveals when obesity is the common thread linking chronic diseases, and when other biology is to blame. Study: Genetics identifies obesity as a ...

A study in The Lancet reveals obesity raises severe infection risk by 70%. Linked to 1 in 10 global infection deaths in 2023, it highlights a dual health burden for rising economies like India.

The Lancet study finds obesity increases risk of hospitalisation or death from infectious diseases like COVID-19 and ...

Medical experts from around the globe proposed a more nuanced approach to diagnosing obesity that does not rely exclusively on body mass index (BMI) alone. Writing in The Lancet Diabetes & ...